early career

Limit: 4* (see number of applications) // Tickets Available: 3

Cancer Data Science // Limit: 1 // Tickets Available: 1

Cancer Control Science // Limit: 1 // Tickets Available: 0 
S. Yeo (Epidemiology and Biostatistics, competitive resubmission)

Molecular Precision/Cancer Prevention // Limit: 1 // Tickets Available: 1 

Other Cancer Research // Limit: 1 // Tickets Available: 1

Number of Applications
Applicant organizations may submit more than one application, provided that each application is scientifically distinct, and each is from a different candidate.

Major divisions (e.g., College of Arts and Sciences, Medical School) of an institution may nominate only one applicant each year.

The William T. Grant Scholars Program supports career development for promising early-career researchers. The program funds five-year research and mentoring plans that significantly expand researchers’ expertise in new disciplines, methods, and content areas.

Nomination Statement Requirements
This statement from the Dean or chairperson of the nominating division should describe why the applicant was selected; an assessment of the applicant’s plan; the applicant’s current and expected future roles in the division; the supporting resources available; the applicant’s current source and amount of salary; and the appointment, promotion, and institutional support plans for the applicant, including a guarantee that 50 percent of the applicant’s paid time will be devoted to research. (Successful examples of nominating statements can be found on the Foundation’s website.)

Focus Areas:

• Reducing Inequality
  • In this focus area, we fund research studies that aim to build, test, or increase understanding of programs, policies, or practices to reduce inequality in the academic, social, behavioral, or economic outcomes of young people ages 5–25 in the United States, along dimensions of race, ethnicity, economic standing, sexual or gender minority status, language minority status, or immigrant origins.
• Improving the Use of Research Evidence
  • In this focus area, we support research on strategies focused on improving the use of research evidence in ways that benefit young people ages 5-25 in the United States. We want to know what it takes to get research used by decision-makers and what happens when research is used. We welcome letters of inquiry for studies that pursue one of these broad aims.
    
    While an extensive body of knowledge provides a rich understanding of specific conditions that foster the use of research evidence, we lack robust, validated strategies for cultivating them. What is required to create structural and social conditions that support research use? What infrastructure is needed, and what will it look like? What supports and incentives foster research use? And, ultimately, how do youth outcomes fare when research evidence is used? This is where new research can make a difference.

Eligible Applicants 

• Applicants must be nominated by their institutions. Major divisions of an institution (e.g., College of Arts and Sciences, Medical School) may nominate only one applicant each year.  In addition to the eligibility criteria below, deans and directors of those divisions should refer to the Review Criteria to aid them in choosing their nominees. Applicants of any discipline are eligible. 

• Applicants must have received their doctorate within seven years of submitting their application. We calculate this by adding seven to the year the doctorate was conferred. In medicine, the seven-year maximum is dated from the completion of the first residency. The month in which the degree was conferred or residency completed  does not matter for this calculation. 

• Applicants must be employed in career-ladder positions. For many applicants, this means holding a tenure-track position in a university. Applicants in other types of organizations should be in positions in which there is a pathway to advancement in a research career at the organization and the organization is fiscally responsible for the applicant’s position. The award may not be used as a post-doctoral fellowship. 

• Applicants outside the United States are eligible. As with U.S. applicants, they must pursue research that has compelling policy or practice implications for youth in the United States. 

• We strive to support a diverse group of researchers in terms of race, ethnicity, gender, and seniority, and we encourage research projects led by Black or African American, Indigenous, Latinx, and/or Asian or Pacific Islander American  researchers.

Limit: 1 // Tickets Available: 0

M.M. Kaelberer (Physiology) 

The current grant level is $300,000; $75,000 per year for a four-year period. For the 2026 award, one nomination will be invited from each of the participating institutions listed at the bottom of this page.

Eligibility

• Candidates must meet all of the following eligibility requirements:
• Hold a doctorate in biomedical sciences, medicine, or a related field, including engineering or the physical sciences.
• As of Sept. 3, 2025, run an independent lab and hold a full-time appointment at the rank of assistant professor. (Appointments such as research assistant professor, adjunct assistant professor, assistant professor research track, visiting professor, or instructor are not eligible).
  • Current appointments such as research assistant professor, adjunct assistant professor, assistant professor research track, visiting professor, or instructor are not eligible to apply.
• Must not have been appointed as an assistant professor and run an independent lab at any institution prior to June 11, 2021, whether or not such an appointment was on a tenure track. Time spent in clinical internships, residencies, in work toward board certification, or on parental leave does not count as part of this four-year limit. Candidates who need an exception on the four-year limit should contact Pew’s program office to ensure that application reviewers are aware an exception has been given.
  • Please note that the eligibility criteria above have been temporarily expanded to account for COVID-related lab shutdowns. This extension will end after this upcoming application cycle. Beginning next year, the eligibility window for the 2027 grant will revert to the three-year period. Please direct any questions to the program office at scholarsapp@pewtrusts.org.
• May apply to the program a maximum of two times. All applicants must be nominated by their institution and must complete the 2026 online application.
• If applicants have appointments at more than one eligible nominating institution or affiliate, they may not reapply in a subsequent year from a different nominating entity.
• May not be nominated for the Pew Scholars Program and the Pew-Stewart Scholars Program for Cancer Research in the same year.

Based on their performance during their education and training, candidates should demonstrate outstanding promise as contributors in science relevant to human health. This program does not fund clinical trials research. Strong proposals will incorporate particularly creative and pioneering approaches to basic, translational, and applied biomedical research. Candidates whose work is based on biomedical principles but who bring in concepts and theories from more diverse fields are encouraged to apply.

Ideas with the potential to produce an unusually high impact are encouraged. Selection of the successful candidates will be based on a detailed description of the work that the applicant proposes to undertake, evaluations of the candidate’s performance, and notable past accomplishments, including honors, awards, and publications. In evaluating the candidates, the National Advisory Committee gives considerable weight to both the project proposal and the researcher, including evidence that the candidate is a successful independent investigator and has the skill set needed to carry out their high-impact proposal.

Funding from the NIH, other government sources, and project grants from nonprofit associations do not pose a conflict with the Pew scholars program. If you have questions concerning eligibility, please contact Pew Biomedical Programs (scholarsapp@pewtrusts.org) in advance of applying.

Funding Terms

An award of $75,000 per year for four years will be provided to the sponsoring institution for use by the scholar, subject to annual review of the scholar’s progress. Grant agreements will be issued in August of the award year. The awarded funds may be used at the discretion of the Pew scholar, for personnel, equipment, supplies, or travel directly related to the scholar's research and as to best advance his or her research and career.

• The amount of the award that may be used for the principal investigator’s salary is limited to $12,500 per year (including benefits) or $50,000 over the duration of the grant. There are no limits on student or postdoctoral salaries.
• Not more than 8 percent ($24,000) of the total award value may be allocated for facilities and administration (F&A) charges or indirect costs (IDCs).
• Should the funds not be immediately required, they may be accumulated and carried over through the grant period and, with written approval of the program office, the grant may receive a no-cost extension for one additional year (without additional funds).
• Subawards are allowed.

Limit:  1  // Tickets Available: 1 

Applicants may submit only one grant application per grant review.

The National Scleroderma Foundation seeks applications from promising new investigators who hold faculty or equivalent positions and who wish to pursue a career in research related to scleroderma. This grant supports promising research that is likely to lead to individual research project grants.Applications may be submitted by domestic non-profit organizations, public and private such as universities, colleges, hospitals, and laboratories. Foreign organizations and institutions are not eligible. These newinvestigator grants may not be used to support thesis or dissertation research or fellowship training. Applicants must have a doctoral degree in Medicine, Osteopathy, Veterinary Medicine or one of the sciences; and must have completed a postdoctoral fellowship by the grant award date. Applicants who have been a principal investigator on grants from the National Scleroderma Foundation or other national, private or government agencies other than fellowship grants are not eligible for this award.

Institutionally coordinated // S. Song (Biomedical Engineering)
For information, please contact: Marie Teemant, Associate for Research Development

The CCR Grants have fostered promising breast cancer researchers who are in the early stages of their faculty careers by providing support for up to three years of “protected time” for research career development under the guidance of a Mentor Committee. The Foundation is especially interested in hypothesis-driven studies that target breast cancer, in the development of strategies for earlier diagnosis, reduce risk of breast cancer, or increase the effectiveness of current therapies to lead to longer and better-quality outcomes for patients.  They may be considered basic, translational, clinical and/or population science. 

Award: Up to $150,000 per year (combined direct and indirect costs) for up to three years ($450,000).

Eligibility:

• Must have a doctoral degree, such as M.D., Ph.D., Dr.P.H., D.O., or equivalent.
• Must currently hold a full-time faculty appointment or have a formal offer letter from the Institution that confirms position and start date by the Application due date (October 9, 2024).
• Must not have held any faculty appointment, including non-tenure and tenure track appointments combined, for more than a total of 6 years by the Application due date.
• Must not simultaneously hold any other Grant awarded by Susan G. Komen.
• Must not currently be or have been a Principal Investigator on an existing NIH R01 grant or their equivalent as of the date of Award Notification (on or around April 15, 2025).
• Must conduct the proposed research and training at the Lead Mentor’s U.S. based institution.
• Must have adequate space and facilities to conduct the proposed research and must be able to devote at least 75% of full-time effort to breast cancer research and activities.

*The University of Arizona Cancer Center (UACC) can nominate up to two applicants but only if at least one of the two nominees identifies as as someone from groups shown to be historically minoritized and marginalized in biomedical research from National Science Foundation data (details outlined in RFA).

For more information please contact UACC-preaward@arizona.edu

Apply to Internal Competition // Limit: 2 // Tickets Available: 2*

This grant mechanism aims to help outstanding senior postdoctoral fellows and clinical fellows, working under the guidance of a mentor, launch their competitive, independent breast cancer research careers. Career Transition Awards provide up to five years of funding in two phases: Phase 1 supports the final years of mentored, postdoctoral training; and Phase 2 supports the independent research of the early career, tenure-track investigators. 

Research projects must be hypothesis-driven, breast cancer-focused studies. They may be considered basic, translational, clinical and/or population science. 

Komen’s research priorities are conquering metastatic and aggressive breast cancers, advancing personalized breast cancer care throughout the continuum of care and eliminating breast cancer disparities and inequities. 

Eligibility:

• Individuals pursuing independent breast cancer research careers who are in the final years of mentored postdoctoral research training positions with no more than five years of total postdoctoral research experience at the time of Letter of Intent submission (August 7, 2024). For this application clinical fellows are considered eligible and equal to the postdoctoral rank.
• Must have a doctoral degree, including M.D., Ph.D., Dr.P.H., D.O., or equivalent.
• May not hold any appointment designated as faculty (e.g., assistant professor, clinical assistant professor, faculty-level instructor, or equivalent). Clinical fellows with the title instructor are allowed as long as they are no more than 5 years into their training similar to above bullet concerning postdoctoral training.
• Must be able to devote at least 75% of full-time effort to breast cancer research and activities, i.e., protected research time.
• Applicant/PI may not hold another career transition award, training award (K-type awards) or R-type award at time of notification of intent to fund (on or around April 15, 2025). If Applicant previously held an R-type award at any point, they are not eligible to apply for this award.
• Is not required to be a U.S. citizen or permanent resident.

*The University of Arizona Cancer Center (UACC) can nominate up to two applicants but only if at least one of the two nominees identifies as as someone from groups shown to be historically minoritized and marginalized in biomedical research from National Science Foundation data (details outlined in RFA).

For more information please contact UACC-preaward@arizona.edu


Apply to Internal Competition // Limit: 2 // Tickets Available: 2*

Limit: 1 // K. Rhodes  (Immunology)

The funds are designed to provide to tenure track faculty members in their first to fourth year, at American Institutions, who hold M.D. and/or Ph.D. degrees, start-up support to move the project forward to the point where R01 or other independent funding can be obtained.  Applicants with current R01 funding should not apply.

Beginning in 2023, the grant provides $75,000 annually for a period of up to three years.  Grants are not renewable.  Institutions may submit one proposal per session.  Interested candidates should work through their sponsored projects office.

Proposals must contain an adequately detailed description of the project to be clearly understandable by the scientific members of the Trustees.  They need not be in the detail requested by the NIH for R01 grants and should not exceed five pages in length.  Additional material can be submitted, but the five-page application should contain the essential information.  References should also be included to support the proposal.  Note that the five page limit is only for the project description.  

A one-two page lay summary must be provided as part of the proposal. Applicants should bear in mind that our Board includes non-scientist members, making this summary of particular importance.  The summary should include the project’s title, and the investigator's contact information.

In addition to the institution providing recognition of an internal selection process resulting in no more than one candidate, (this requires just a sentence that may be included in the letters), the proposal must be accompanied by letters of approval by the Dean of the medical school and/or another senior faculty member or members who can represent the support of the institution and who are acquainted with the qualifications of the applicant and the potential impact of his/her work.

Limit: 1 // K. Rhodes  (Immunology)

The funds are designed to provide to tenure track faculty members in their first to fourth year, at American Institutions, who hold M.D. and/or Ph.D. degrees, start-up support to move the project forward to the point where R01 or other independent funding can be obtained.  Applicants with current R01 funding should not apply.

Beginning in 2023, the grant provides $75,000 annually for a period of up to three years.  Grants are not renewable.  Institutions may submit one proposal per session.  Interested candidates should work through their sponsored projects office.

Proposals must contain an adequately detailed description of the project to be clearly understandable by the scientific members of the Trustees.  They need not be in the detail requested by the NIH for R01 grants and should not exceed five pages in length.  Additional material can be submitted, but the five-page application should contain the essential information.  References should also be included to support the proposal.  Note that the five page limit is only for the project description.  

A one-two page lay summary must be provided as part of the proposal. Applicants should bear in mind that our Board includes non-scientist members, making this summary of particular importance.  The summary should include the project’s title, and the investigator's contact information.

In addition to the institution providing recognition of an internal selection process resulting in no more than one candidate, (this requires just a sentence that may be included in the letters), the proposal must be accompanied by letters of approval by the Dean of the medical school and/or another senior faculty member or members who can represent the support of the institution and who are acquainted with the qualifications of the applicant and the potential impact of his/her work.

Limit: 1 // Next funding cycle August 1st, 2025*

Due to an update in the guidelines, the foundation will not accept proposals during 2024. If still eligible, the PI selected for 2024 will be submitted during 2025.

PI Selected: K. Rhodes  (Immunology)

The funds are designed to provide to tenure track faculty members in their first to fourth year, at American Institutions, who hold M.D. and/or Ph.D. degrees, start-up support to move the project forward to the point where R01 or other independent funding can be obtained.  Applicants with current R01 funding should not apply.

Beginning in 2023, the grant provides $75,000 annually for a period of up to three years.  Grants are not renewable.  Institutions may submit one proposal per session.  Interested candidates should work through their sponsored projects office.

Proposals must contain an adequately detailed description of the project to be clearly understandable by the scientific members of the Trustees.  They need not be in the detail requested by the NIH for R01 grants and should not exceed five pages in length.  Additional material can be submitted, but the five-page application should contain the essential information.  References should also be included to support the proposal.  Note that the five page limit is only for the project description.  

A one-two page lay summary must be provided as part of the proposal. Applicants should bear in mind that our Board includes non-scientist members, making this summary of particular importance.  The summary should include the project’s title, and the investigator's contact information.

In addition to the institution providing recognition of an internal selection process resulting in no more than one candidate, (this requires just a sentence that may be included in the letters), the proposal must be accompanied by letters of approval by the Dean of the medical school and/or another senior faculty member or members who can represent the support of the institution and who are acquainted with the qualifications of the applicant and the potential impact of his/her work.